Autolus is a CAR T cell therapy company. We are applying our extensive programming capabilities to develop advanced autologous T cell therapies that have the potential to deliver life-changing therapies to patients with cancer and autoimmune diseases.
Headquarters:
United Kingdom of Great Britain and Northern Ireland
Company Type:
MNC / Large Enterprise
Company size:
501-1,000 Employees
Year Founded:
2014 (11 years)
Address:
AUTOLUS LIMITED; LONDON, W12 7RZ, GB
HIGH
spending power